In South Korea, an intermediate TB-burden country, clinicians prescribe anti-TB medication after identifying pleural fluid characteristics such as lymphocytic exudates with high ADA levels (>40 U/L) before microbiological confirmation of MTB, which is based on the Korea Guidelines for Tuberculosis. Here, ADA is linked to tuberculosis.